Putting Patients First Blog

MARCH 18, 2024

Additionally, incorporating beneficiary feedback and pilot testing of revised Evidence of Coverage documents can ensure that MPPP information clarifies rather than complicates coverage understanding. For the Annual Notice of Change, accessible language that accommodates varied health literacy levels is vital.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Mail-Order Pharmacies 40

Putting Patients First Blog

MARCH 18, 2024

Additionally, incorporating beneficiary feedback and pilot testing of revised Evidence of Coverage documents can ensure that MPPP information clarifies rather than complicates coverage understanding. For the Annual Notice of Change, accessible language that accommodates varied health literacy levels is vital.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Mail-Order Pharmacies 40

PharmaTech

JUNE 6, 2025

Biosimilars continue to build as a sector of this market with an estimated 2025 value in the region of US$42 billion (1). While the document itself is a quarter of a century old at this point, it is laid out in such a way that relevancy is maintained.

Dosage 52

Dosage Drug Development Documentation Biosimilars 52

European Pharmaceutical Review

APRIL 14, 2025

In the UK, the Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024 1 have passed through the UK legislative procedure and will apply from 23 July 2025. In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC).

Hospitals 52

Hospitals Documentation Packaging Communication 52

PharmaShots

JUNE 1, 2023

These new results reinforce our differentiating data package for PDC*lung01. After the completion of the current clinical study with PDC*lung01 (PDC-LUNG-101), we plan to conduct a randomized, open-label phase 2 clinical trial with PDC*lung in the B2 cohort setting (2025 to 2028).

Immunity 40

Immunity Immunization Vaccines Health and Personal Care Stores 40

FDA Law Blog: Biosimilars

JANUARY 20, 2025

Nearly two years after FDA issued draft guidance on Labeling of Plant-Based Milk Alternatives and Voluntary Nutrient Statements , on January 6, 2025, FDA released draft guidance document on plant-based labeling, Labeling Plant-Based Alternatives to Animal-Derived Foods. The description or name of the food (i.e.,

Labelling 52

Labelling Documentation Packaging 52

Express Pharma

MAY 14, 2025

Coding standards group GS1 will be holding its General Assembly from May 19 to 23, 2025 [1]. Each proposition is grounded in a set of assertions that are supported by extant evidence from published articles or publicly available documents. The security problems associated with QR codes are now coming to light in India.

Packaging 59

Packaging Documentation 59

PharmaVoice

JUNE 11, 2025

Published June 11, 2025 Amy Baxter Staff Reporter post share post print email license Win McNamee via Getty Images Listen to the article 5 min This audio is auto-generated. The 1,000-plus page document is full of tax and spending cuts, including some significant changes that will impact pharma and the larger healthcare industry.

Drug Pricing 147

Drug Pricing Packaging Documentation 147

BioPharma Dive

JUNE 12, 2025

Published June 12, 2025 Amy Baxter Staff Reporter post share post print email license Win McNamee via Getty Images First published on The budget bill currently under consideration in Congress is big — and it’s complicated. By Jacob Bell • May 6, 2025 Keep up with the story.

Drug Pricing 52

Drug Pricing Packaging Vaccines Documentation 52